It was previously thought that EpCAM and E-Cadherin have opposing functions because EpCAM is highly expressed in different carcinomas and its knockdown represses cancer cell proliferation, whereas lower expression of E-cadherin in tumour cells has been found to be associated with epithelial–mesenchymal transition, promoting metastasis [27, 28]. Here, CDH1 is linked to cancer.